History Of Pharmacy Research Articles

“Time Capsules” of Science: Museums, Collections, and Scientific Heritage in Portugal

AbstractThe term “museum” means different things in different periods, to be sure; nonetheless, over the past 250 years in Portugal the state failed in creating a national, sustainable museum of science. This essay analyzes, in broad terms, the context, relevance, and consequences of this absence for Portuguese scientific museums, collections, and heritage. It also discusses the implications for the history of science and, especially, for the public interpretation of the past. The term “museum of science” is used in a broad sense, encompassing museums with collections of scientific instruments, medicine, pharmacy, and natural history, including botanic gardens. Museums of technology and industry, however, are outside the scope of this discussion.

Twenty Years with Glenn Sonnedecker and AIHP:

Everything began in 1990 with a question from Ursula Heyer (1922-2007), who studied pharmacy and the history of pharmacy at the University of Wisconsin during the 1950s: “Would you like to have my books by Georg Urdang?” After a long professional career as the head pharmacist at a hospital in

Dissertations in the History of Pharmacy

Dissertations in the History of Pharmacy

History of pharmacy in Jagodina district in Serbia

The aim of this study was to analyze and emphasize the importance of contemporary pharmacy which enabled development of modern health care system in Jagodina district in Serbia. Material and method: The research was descriptive, document analysis methods, desk analysis of secondary data and of historical synthesis were used. It covered the historical period from the 12th century till the modern age. The first owner of the pharmacy in Serbia in XIX century was Anton Delini in 1813. The first pharmacy in Jagodina was founded by Mr. Djordje Krstic on August 22nd, 1852 and it was very important for the health care development in Jagodina district. Conclusions: Pioneers in the development of pharmacy in Jagodina had an important impact on the socio-economic and cultural development of this region.

Dissertations in the History of Pharmacy

Dissertations in the History of Pharmacy

Dissertations in the History of Pharmacy

O’Donnell, Kelly Suzanne. “The Political is Personal: Barbara Seamen and the History of the Women’s Health Movement,” Yale University, Ph.D., 2015, 228 pp., 100103688. Journalist and activist Barbara Seaman (1935-2008) is widely celebrated as one of the founding mothers of the American

Dissertations in the History of Pharmacy

Parrish, Sean David. “Marketing nature: Apothecaries, medicinal retailing, and scientific culture in early modern Venice, 1565-1730,” Duke University, Ph.D., 2015, 302 p., 373820. This study examines the contributions of apothecary craftsmen and their medicinal retailing practices to emerging

Glenn Sonnedecker: A Brief Biography & A Bibliography of His Publications (1948-2002)

Glenn Sonnedecker, pharmacist and editor, received his Ph.D. in the History of Pharmacy and History of Science from the University of Wisconsin in 1952. After completing his degree, he succeeded George Urdang, who, from 1947-1952 at UW, had been the first Professor of the History of Pharmacy in the

George Urdang and the Founding of the German Society for the History of Pharmacy

Unlike in France, there was no history of pharmacy society in the German-speaking world at the beginning of the 1920s. It was only with the founding of the Society for the History of Pharmacy in Innsbruck in 1926 that the situation changed. However, the dispute as to whether the society should be German in terms of language and culture or international in scope lasted for three decades. It was not until 1950 that George Urdang changed his mind and agreed to the establishment of an international organization. In this context, this article also examines the question of when the Society first presented itself as a national group and, with the rediscovery of a document on the “inaugural meeting,” provides a new contribution to the question: When was the German Society for the History of Pharmacy founded?

Influence of Arabian Pharmacy on Diseases Tretament During Ottoman's Period in Bosnia and Herzegovina.

The Arab cultural heritage was an era of invaluable preservation and development of numerous teachings, including biomedical sciences. The golden period of Arab medicine deserves special attention in the history of medicine and pharmacy, as it was the period of rapid translation of works from Greek and Persian cultures into Arabic. They preserved their culture, and science from decay, and then adopted them to continue building their science on theirs as a basis. After the fall of Arabian Caliphate, Arabian pharmacy, continued to persevere, and spread through Turkish Caliphate until its fall in the First World War. That way, Arabian pharmacy will be spread to new areas that had benefited from it, including the area of occupied Bosnia and Herzegovina. Because of the vast territorial scope of the Ottoman Empire, the focus of this paper is description of developing pharmacy in Bosnia and Herzegovina during the time of Ottoman reign.

“Antidotarium ” of Nicholas of Salerno : the history of the pharmacopoeia

The purpose of the article is a textual analysis and identification of practical relevance in the contemporary world of medieval manuscript “Antidotarium” of Nicholas of Salerno – an essential source for the history of pharmacy, containing samples of prescription formulas, leading its history through nine centuries, and tested empirically in countless patients. Materials and methods. To achieve this goal we have analyzed, compared and reviewed existing thematic complexes of literary and historical sources available in medieval medicine, including existing official translations of this manuscript. The result is a detailed analysis and comparison of the original manuscript of the XII th century and the official translations of “Antidotarium” of Nicholas of Salerno in medieval English, Dutch and French. The authors are also discussing the identity of the Nicholas of Salerno and the history of his manuscript, its editing, and the influence that the book has provided on the development and evolution of medicine and pharmacy in Europe as a whole. Conclusion. By defining and showing the history of the “Antidotarium” of Nicholas of Salerno, the authors give an opinion on the high practical significance of this manuscript and the possibility of applying the manuscript formulas in the modern world of evidentiary scientific medicine. The question of the need to translate the medieval source into the Russian language is raised, which will make it possible for the first time in Russian literature to examine in detail the rich medieval prescription of “Antidotarium”, and the need for a further careful and detailed analysis of the translation of the manuscript into the realities of modern evidentiary medicine, rational pharmacotherapy and herbal medicine. Authors have the option of making the translation from medieval French, as one of the closest to the classical Latin languages.

A Golden Year for the British Society for the History of Pharmacy

A Golden Year for the British Society for the History of Pharmacy

Report on Questionnaire Survey for Education of History of Pharmacy in Faculties of Pharmaceutical Science in Japan

Report on Questionnaire Survey for Education of History of Pharmacy in Faculties of Pharmaceutical Science in Japan

George Urdang and the Founding of the German Society for the History of Pharmacy

George Urdang and the Founding of the German Society for the History of Pharmacy

From the Files, edited by Beth D. Fisher

On Thursday, October 19, 1950, New Orleans’ Pharmacie Française de Louis J. Dufilho was officially dedicated, and the museum collection was opened to the public. The dedication ceremony featured speeches by George Urdang, the founding director of the American Institue of the History of Pharmacy,

A Golden Year for the British Society for the History of Pharmacy

A Golden Year for the British Society for the History of Pharmacy

Summary Minutes Annual Business Meeting

With 13 AIHP members present, constituting a quorum, the annual Business Meeting teleconference of the American Institute of the History of Pharmacy was called to order by President William Zellmer on 13 December 2017 at 3:05 PM EST. Executive Director Gregory Higby summarized his Director’s

RPS museum promoted at the British Society for the History of Pharmacy's annual conference

RPS museum promoted at the British Society for the History of Pharmacy's annual conference

Summary Minutes Annual Business Meeting

The annual Business Meeting teleconference of the American Institute of the History of Pharmacy was called to order on 30 November 2016 at 2:00 PM EST. The Minutes of the 2015 Annual Business Meeting, as published in Pharmacy in History 57 (2015): 93-100 were approved. President Zellmer thanked

Therapeutic Proofs and Medical Truths: The Enduring Legacy of Early Modern Drug Trials.

Therapeutic Proofs and Medical Truths:The Enduring Legacy of Early Modern Drug Trials Jeremy A. Greene (bio) "It would be a fruitless enterprise," Owsei Temkin wrote in 1964, "to enter upon speculations on the origins of drug therapy. Suffice to say that it is very old."1 All the same, modernists like to think of the practice of clinical trials for drug therapy as a relatively new thing in the world. Many of my clinical colleagues consider the randomized controlled trial (RCT) the central element in modern medical epistemology, a "gold standard" that neatly divides the evidence-based medicine of the present from the evidence-free medicine of the premodern past.2 Coming to terms with the clinical trial as an older form of medical evidence, with roots in princely politics and prisoner pardons, is a more challenging task. Likewise, historians of science often leave medicine out of the broader history of experiment. In spite of the efforts of a number of scholars to locate medicine as a central site for the development of empirical and experimental knowledge in the medieval and early modern period, it has been far too easy for historians to casually refer to the incorporation of experiment into medicine as something that develops only in the nineteenth and twentieth centuries.3 As the editors of this special issue of the Bulletin of the History of Medicine point out, this omission occurs because [End Page 420] drug testing has remained a relatively understudied area among historians of medieval and early modern medicine. In directly challenging both of these assumptions, the articles of this volume constitute a powerful and important intervention that demonstrates the direct relevance of early modern European history of pharmacy and therapeutics to present-day practitioners as well as historians of science, medicine, and technology. True, the methodology of the trials they document might not pass muster with a twenty-first-century Institutional Review Board, a National Institutes of Health study section, or the editorial board of The Lancet, but the forms traced in these essays bear enough genealogical similarities to present-day therapeutic proofs to be sufficiently unsettling. At the very least, they give the lie to the casual assumption that the modern form of therapeutic proof was simply the intellectual accomplishment of Austin Bradford Hill in his MRC offices in 1948. Rather, the reader of this volume finds that the things we do for proof today have roots that stretch back centuries and are as steeped in the social relations of state power, the role of expert knowledge in the bureaucratic systems, and the marketing strategies of drug manufacturers as they are in any purity of method or philosophical principle. One comes away from this collection of articles with a greater awareness of the cracks in the edifice of therapeutic truth-making that twenty-first-century pharmaceutical manufacturers, physicians, and patients have come to inhabit. The period, place, actors, and scope of action in these contributions range widely, from Michael McVaugh's opening article on experimental protocols for drug provings among the fourteenth-century medical faculty of Montpellier to the eighteenth-century attempt to understand and replicate the blood miracle of St. Januarius, chronicled in Francesco Paolo de Ceglia's concluding essay. The drugs tested vary from bath waters to the blood of saints, from pancreatic extracts to whole chickens; the sites of analysis range across French and German courts, learned societies, hospitals, pharmacies, and households; and the actors cross in and out of learned societies, academic institutions, state regulators, and orthodox medical professionals. And yet the contributions of all scholars cohere around several points of continued interest to therapeutic practice and experimental proof today: the relation of reason, rationality, and experiment; the problem of designating on whose bodies such proofs should be tested; and the broader social role that methods for designating legitimate from illegitimate cures play in the relation of the medical profession [End Page 421] and the regulatory state in shaping markets and monopolies for medical practice and pharmaceutical manufacture. ________ For more than two decades, Harry Marks's The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990 has served as a key reference work...